Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27842102 | 0.98 | SMN1; SMN2 (0.40) | GPR84FFAR1CPB2SMN1; SMN2KMT2A | |
| SCHEMBL9773213 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL7522764 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL7515147 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL1683717 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL6049889 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL7519047 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL509990 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL2877290 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 | |
| SCHEMBL5812678 | 0.84 | GPR84 (0.61) | GPR84FFAR1MAPTZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117430849-B | Long side chain polyaromatic alkane anion exchange membrane and preparation method thereof | 大连理工大学 | 2024-02-23 | — | — | CN | disclosed |
| CN-117430849-A | Long side chain polyaromatic alkane anion exchange membrane and preparation method thereof | 大连理工大学 | 2024-01-23 | — | — | CN | disclosed |
| EP-2394979-B1 | INTERMEDIATE OF CILASTATIN AND PREPARATION METHOD THEREOF | ZHEJIANG HISOAR PHARMACEUTICAL CO LTD (CN) | 2014-11-05 | — | — | EP | disclosed |
| US-8822716-B2 | Intermediate of cilastatin and preparation method thereof | ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD (CN) | 2014-09-02 | — | — | US | disclosed |
| US-20110319653-A1 | Intermediate of Cilastatin and Preparation Method Thereof | ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD (CN) | 2011-12-29 | — | — | US | disclosed |
| EP-2394979-A1 | INTERMEDIATE OF CILASTATIN AND PREPARATION METHOD THEREOF | Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) | 2011-12-14 | — | — | EP | disclosed |
| CN-101265187-B | Method for preparing ethyl 7-chloro-2-oxyheptanoate | TAICANG PUYUAN CHEMICAL CO LTD | 2011-09-21 | — | — | CN | disclosed |
| CN-101265187-A | Method for preparing ethyl 7-chloro-2-oxyheptanoate | TAICANG PUYUAN CHEMICAL CO LTD (CN) | 2008-09-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319653-A1 | Intermediate of Cilastatin and Preparation Method Thereof | CYP8B1, DHCR7, HMGCR | GPR84 3826/4885FFAR1 1611/4885CPB2 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.